85075209
Jun 30, 2010
May 24, 2011
Pharmaceuticals derived from recombinant DNA technology for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Pharmaceuticals